Patrik Oleksak

Dr. Patrik Oleksak

University of Hradec Kralove
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SNSweta Nidhi
Sweta Nidhi
UAUttpal Anand
Uttpal Anand
POPatrik Oleksak
Patrik Oleksak
PTPooja Tripathi
Pooja Tripathi
JLJonathan Lal
Jonathan Lal
VTVijay Tripathi
Vijay Tripathi
According to Darwin’s theory, endless evolution leads to a revolution. One such example is the Clustered Regularly Interspaced Palindromic Repeats (CRISPR)–Cas system, an adaptive immunity system in most archaea and many bacteria. Gene editing technology possesses a crucial potential to dramatically impact miscellaneous areas of life, and CRISPR–Cas represents the most suitable strategy. The system has ignited a revolution in the field of genetic engineering. The ease, precision, affordability of this system is akin to a Midas touch for researchers editing genomes. Undoubtedly, the applications of this system are endless. The CRISPR–Cas system is extensively employed in the treatment of infectious and genetic diseases, in metabolic disorders, in curing cancer, in developing sustainable methods for fuel production and chemicals, in improving the quality and quantity of food crops, and thus in catering to global food demands. Future applications of CRISPR–Cas will provide benefits for everyone and will save countless lives. The technology is evolving rapidly; therefore, an overview of continuous improvement is important. In this review, we aim to elucidate the current state of the CRISPR–Cas revolution in a tailor-made format from its discovery to exciting breakthroughs at the application level and further upcoming trends related to opportunities and challenges including ethical concerns.

10 September 2020 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
Qinghua WuQinghua Wu
Qinghua Wu
ZQZihui Qin
Zihui Qin
KKKamil Kuca
Kamil Kuca
LYLi You
Li You
YZYingying Zhao
Yingying Zhao
Xu WangXu Wang
Xu Wang

1 August 2021 in Saudi Pharmaceutical Journal
Verified
Journal Article
Open access
SHSwati Halder
Swati Halder
UAUttpal Anand
Uttpal Anand
SNSamapika Nandy
Samapika Nandy
POPatrik Oleksak
Patrik Oleksak
SQSafaa Qusti
Safaa Qusti
ADAbhijit Dey
Abhijit Dey
Memory, one of the most vital aspects of the human brain, is necessary for the effective survival of an individual. ‘Memory’ can be defined in various ways but in an overall view, memory is the retention of the information that the brain grasps. Different factors are responsible for the disbalance in the brain’s hippocampus region and the acetylcholine level, which masters the memory and cognitive functions. Plants are a source of pharmacologically potent drug molecules of high efficacy. Recently herbal medicine has evolved rapidly, gaining great acceptance worldwide due to their natural origin and fewer side effects. In this review, the authors have discussed the mechanisms and pharmacological action of herbal bioactive compounds to boost memory. Moreover, this review presents an update of different herbs and natural products that could act as memory enhancers and how they can be potentially utilized in the near future for the treatment of severe brain disorders. In addition, the authors also discuss the differences in biological activity of the same herb and emphasize the requirement for a higher standardization in cultivation methods and plant processing. The demand for further studies evaluating the interactions of herbal drugs is mentioned.

28 May 2021 in Plants
Verified
Journal Article
Open access
PDF file
ABAcharya Balkrishna
Acharya Balkrishna
ARAkansha Rohela
Akansha Rohela
AKAbhishek Kumar
Abhishek Kumar
AKAshwani Kumar
Ashwani Kumar
VAVedpriya Arya
Vedpriya Arya
Kamil KucaKamil Kuca
Kamil Kuca
Drug resistance among microbial pathogens and oxidative stress caused by reactive oxygen species are two of the most challenging global issues. Firstly, drug-resistant pathogens cause several fatalities every year. Secondly aging and a variety of diseases, such as cardiovascular disease and cancer, are associated with free radical generated oxidative stress. The treatments currently available are limited, ineffective, or less efficient, so there is an immediate need to tackle these issues by looking for new therapies to resolve resistance and neutralize the harmful effects of free radicals. In the 21st century, the best way to save humans from them could be by using plants as well as their bioactive constituents. In this specific context, Jasminum is a major plant genus that is used in the Ayurvedic system of medicine to treat a variety of ailments. The information in this review was gathered from a variety of sources, including books, websites, and databases such as Science Direct, PubMed, and Google Scholar. In this review, a total of 14 species of Jasminum have been found to be efficient and effective against a wide variety of microbial pathogens. In addition, 14 species were found to be active free radical scavengers. The review is also focused on the disorders related to oxidative stress, and it was concluded that Jasminum grandiflorum and J. sambac normalized various parameters that were elevated by free radical generation. Alkaloids, flavonoids (rutoside), terpenes, phenols, and iridoid glucosides are among the main phytoconstituents found in various Jasminum species. Furthermore, this review also provides insight into the mechanistic basis of drug resistance, the generation of free radicals, and the role of Jasminum plants in combating resistance and neutralizing free radicals.

6 June 2021 in Molecules
Verified
Journal Article
Open access
PDF file
HKHarsh Kumar
Harsh Kumar
Kanchan BhardwajKanchan Bhardwaj
Kanchan Bhardwaj
Natália Cruz-MartinsNatália Cruz-Martins
Natália Cruz-Martins
Eugenie  NepovimovaEugenie Nepovimova
Eugenie Nepovimova
POPatrik Oleksak
Patrik Oleksak
Kamil KucaKamil Kuca
Kamil Kuca
The ingestion of contaminated water and food is known to cause food illness. Moreover, on assessing the patients suffering from foodborne disease has revealed the role of microbes in such diseases. Concerning which different methods have been developed for protecting food from microbes, the treatment of food with chemicals has been reported to exhibit an unwanted organoleptic effect while also affecting the nutritional value of food. Owing to these challenges, the demand for natural food preservatives has substantially increased. Therefore, the interest of researchers and food industries has shifted towards fruit polyphenols as potent inhibitors of foodborne bacteria. Recently, numerous fruit polyphenols have been acclaimed for their ability to avert toxin production and biofilm formation. Furthermore, various studies have recommended using fruit polyphenols solely or in combination with chemical disinfectants and food preservatives. Currently, different nanoparticles have been synthesized using fruit polyphenols to curb the growth of pathogenic microbes. Hence, this review intends to summarize the current knowledge about fruit polyphenols as antibacterial agents against foodborne pathogens. Additionally, the application of different fruit extracts in synthesizing functionalized nanoparticles has also been discussed.

5 March 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
RDRNDr. Patočka, DrSc.
RNDr. Patočka, DrSc.
Kamil KucaKamil Kuca
Kamil Kuca
POPatrik Oleksak
Patrik Oleksak
Eugenie  NepovimovaEugenie Nepovimova
Eugenie Nepovimova
MVMartin Valis
Martin Valis
Blanka KlimovaBlanka Klimova
Blanka Klimova
Since December 2019, SARS-CoV-2 (COVID-19) has been a worldwide pandemic with enormous consequences for human health and the world economy. Remdesivir is the only drug in the world that has been approved for the treating of COVID-19. This drug, as well as vaccination, still has uncertain effectiveness. Drug repurposing could be a promising strategy how to find an appropriate molecule: rapamycin could be one of them. The authors performed a systematic literature review of available studies on the research describing rapamycin in association with COVID-19 infection. Only peer-reviewed English-written articles from the world’s acknowledged databases Web of Science, PubMed, Springer and Scopus were involved. Five articles were eventually included in the final analysis. The findings indicate that rapamycin seems to be a suitable candidate for drug repurposing. In addition, it may represent a better candidate for COVID-19 therapy than commonly tested antivirals. It is also likely that its efficiency will not be reduced by the high rate of viral RNA mutation.